Related Experiment Video
Updated: Jun 17, 2026

11:10
Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Published on: November 16, 2011
Hypertriglyceridemia with increased plasma insulin concentrations in cats
1School of Veterinary Medicine, Nippon Veterinary and Life Science University, 1-7-1 Kyonancho, Musashino, Tokyo 180-8602, Japan.
Research in Veterinary Science
|January 19, 2010
Summary
A new criterion for feline hypertriglyceridemia (hyper-TG) with increased insulin identifies early lipid metabolism issues. This helps diagnose obesity and related abnormalities in cats.
Area of Science:
- Veterinary Medicine
- Metabolic Disorders
- Companion Animal Health
Background:
- Lipid metabolism abnormalities, including obesity, are common in cats.
- Early diagnosis is crucial for effective management and prevention of secondary complications.
- Current diagnostic criteria may not fully capture early-stage metabolic dysfunction.
Purpose of the Study:
- To establish a new diagnostic criterion for feline hypertriglyceridemia (hyper-TG) characterized by increased plasma insulin concentrations.
- To identify key plasma biomarkers for the early diagnosis of lipid metabolism abnormalities and obesity in cats.
- To determine the prevalence of this newly defined hyper-TG condition in different age groups of cats.
Main Methods:
- Plasma samples were collected from 142 client-owned cats of various ages and breeds.
- Measurements included metabolite, insulin, and adiponectin concentrations, along with LDH, AST, and ALT activities.
- A new criterion for hyper-TG was defined as plasma triglyceride (TG) concentrations over 165 mg/dL with increased plasma insulin.
Main Results:
- The prevalence of hyper-TG was 16.7% in young cats (1-6 years) and 18.3% in older cats (>7 years).
- Hyper-TG cats exhibited 6.6-7.4-fold higher plasma TG concentrations compared to controls.
- Significant increases in plasma cholesterol, FFA, insulin, LDH, and ALT, and a significant decrease in adiponectin were observed in hyper-TG cats.
Conclusions:
- The new criterion of hypertriglyceridemia with increased insulin aids in the early diagnosis of lipid metabolism abnormalities in cats.
- Increased plasma TG, insulin, LDH, and ALT, coupled with decreased adiponectin, are key indicators for early detection.
- Hyper-TG cats showed signs consistent with early-stage obesity, characterized by elevated insulin and reduced adiponectin levels.
Related Concept Videos
Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Acute Pancreatitis I: Introduction
Acute pancreatitis is the sudden inflammation of the pancreas caused by the early activation of digestive enzymes, leading to the autodigestion of pancreatic tissue. This results in local inflammation and, in severe cases, systemic complications.EtiologyUnderstanding the underlying causes is crucial, as identifying the etiology guides treatment and anticipates complications. Acute pancreatitis can be triggered by various factors, typically grouped into the following clinical categories.Biliary...
Acute Pancreatitis II: Clinical Manifestations and Management
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
Dipeptidyl Peptidase 4 Inhibitors
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
Acute Pancreatitis II: Pathophysiology
The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
Insulin Secretory Vesicles
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...

